Merck (MRK) Beats On Q1 Earnings, Lags Sales, Raises Outlook

Merck & Co., Inc. reported first-quarter 2018 adjusted earnings of $1.05 per share, which beat Zacks' Consensus Estimate of 99 cents by 6.1%. Earnings rose 19.3% year over year attributable to slightly higher sales and lower R&D costs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.